New hope for lung cancer patients after standard treatment fails
NCT ID NCT02442349
Summary
This study tested an experimental drug called AZD9291 for people in Asia Pacific with advanced non-small cell lung cancer. The participants had a specific genetic change (T790M mutation) and their cancer had gotten worse despite previous treatment with a common type of targeted therapy. The main goal was to see if the new drug could safely shrink their tumors and control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Kogarah, 2217, Australia
-
Research Site
Nedlands, 6009, Australia
-
Research Site
Woolloongabba, 4102, Australia
-
Research Site
Beijing, 100021, China
-
Research Site
Beijing, 100142, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changchun, 130000, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chongqing, 400038, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Fuzhou, 350014, China
-
Research Site
Haikou, 570311, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310006, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150049, China
-
Research Site
Jinan, 250117, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Shanghai, 200030, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shanghai, CN-200433, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Xi'an, 710032, China
-
Research Site
Xi'an, 710038, China
-
Research Site
Zhengzhou, 450008, China
-
Research Site
Goyang-si, 10408, South Korea
-
Research Site
Seongnam-si, 13620, South Korea
-
Research Site
Seoul, 05505, South Korea
-
Research Site
Seoul, 6351, South Korea
Conditions
Explore the condition pages connected to this study.